Ticker Details
Black Diamond Therapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$126.97M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.36 | 4.13%
Avg Daily Range (30 D):	$0.04 | 2.34%
Avg Daily Range (90 D):	$0.10 | 3.88%

Institutional Daily Volume
Avg Daily Volume:	.77M
Avg Daily Volume (30 D):	.61M
Avg Daily Volume (90 D):	1.27M

Trade Size
Avg Trade Size (Sh.):	148
Avg Trade Size (Sh.) (30 D):	149
Avg Trade Size (Sh.) (90 D):	175

Institutional Trades
Total Institutional Trades:	386
Avg Institutional Trade:	$1.8M
Avg Institutional Trade (30 D):	$.62M
Avg Institutional Trade (90 D):	$1.37M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.24M
Avg Closing Trade (30 D):	$.62M
Avg Closing Trade (90 D):	$2M
Avg Closing Volume:	208.78K

News

May 26, 2026 @ 3:31 PM What's Going On With Black Diamond Therapeutics St... Source: Lekha Gupta

May 22, 2026 @ 12:00 PM Black Diamond Therapeutics to Participate in Jeffe... Source: Na

Aug 7, 2025 @ 12:23 PM Black Diamond (BDTX) Q2 Loss Narrows 47% Source: Jesterai

Aug 1, 2025 @ 4:21 PM Clarus (CLAR) Q2 Loss Beats Estimates Source: Jesterai

Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.75	$-.17	$-.16
Diluted EPS	$-.74	$-.17	$-.16
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-42.56M	$-9.91M	$-9.04M
Operating Income / Loss	$-51.9M	$-12.06M	$-11.26M
Cost of Revenue
Net Cash Flow	$-10.79M	$-10.88M	$9.08M
PE Ratio